You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美康生物(300439.SZ):擬與啟夏資本等設合夥企業 主投生物醫藥醫療大健康產業
格隆匯 11-25 19:48

格隆匯11月25日丨美康生物(300439.SZ)公佈,2021年11月25日,公司與寧波啟夏私募基金管理有限公司(“啟夏資本”)共同簽署了《生物醫藥大健康基金合作意向書》。基於公司發展戰略並優化投資結構,公司擬與啟夏資本等共同發起設立XX生物醫藥大健康股權投資合夥企業(有限合夥)(以市場監督管理部門最終核准登記為準),投資方向以生物醫藥醫療大健康產業為主

基金規模人民幣7億元,其中美康生物認繳出資人民幣5億元,其他有限合夥人合計認繳出資人民幣2億元,各有限合夥人根據最終簽署的合夥協議確定的出資安排履行出資義務。

基金投資方向專注生物醫藥醫療大健康產業投資(重點專注於生物藥CDMO產業以及其上下游投資/併購)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account